These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4607678)
1. [Problems in the combined therapy of radiation and chemotherapeutic agents]. Morita K Rinsho Hoshasen; 1974 May; 19(5):329-37. PubMed ID: 4607678 [No Abstract] [Full Text] [Related]
2. Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation. Teicher BA; Herman TS; Frei E Important Adv Oncol; 1992; ():39-59. PubMed ID: 1582677 [No Abstract] [Full Text] [Related]
3. Modification of radiotherapy by radiosensitizers and cancer chemotherapeutic agents. II. Cancer chemotherapeutic agents. Looney WB; Hopkins HA Semin Oncol; 1989 Jun; 16(3):176-9. PubMed ID: 2658081 [No Abstract] [Full Text] [Related]
4. [Current status of anticancer chemotherapy. Progress in concept, methods and means]. Chauvergne J Rev Laryngol Otol Rhinol (Bord); 1977; 98(5-6):271-89. PubMed ID: 897407 [No Abstract] [Full Text] [Related]
7. [Observations on the use of a recent antineoplastic drug (methylhydrazine) associated with radiotherapy]. Agati G Minerva Radiol; 1968 Sep; 13(9):470-8. PubMed ID: 5726968 [No Abstract] [Full Text] [Related]
8. Hyperthermia with drugs: current status. Bleehen NM Strahlentherapie; 1984 Dec; 160(12):721-4. PubMed ID: 6393455 [No Abstract] [Full Text] [Related]
9. Chemical modifiers of cancer treatment. Part 2. Clearwater, Florida, 20-24 October 1985. Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1271-545. PubMed ID: 3759545 [No Abstract] [Full Text] [Related]
10. Oxygen delivery: implications for the biology and therapy of solid tumors. Rockwell S Oncol Res; 1997; 9(6-7):383-90. PubMed ID: 9406244 [TBL] [Abstract][Full Text] [Related]
11. Facing fearful odds--a conference summary. Hall EJ Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1023-6. PubMed ID: 3744925 [No Abstract] [Full Text] [Related]
12. [Chemoradiation for malignant brain tumors]. Matsutani M Gan To Kagaku Ryoho; 1997 Nov; 24(14):2042-8. PubMed ID: 9388512 [TBL] [Abstract][Full Text] [Related]
13. Chemical modification of radiation and chemotherapy. Brown JM; Hall EJ; Hirst DG; Kinsella TJ; Kligerman MM; Mitchell JB; Travis EJ; Valeriote F Am J Clin Oncol; 1988 Jun; 11(3):288-303. PubMed ID: 3289362 [No Abstract] [Full Text] [Related]
14. New radiosensitizing regimens, drugs, prodrugs, and candidates. Vallerga AK; Zarling DA; Kinsella TJ Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960 [TBL] [Abstract][Full Text] [Related]
17. [Combination radio and chemotherapy from the viewpoint of the medical oncologist]. Engelhardt R Strahlentherapie Sonderb; 1978; 75():88-95. PubMed ID: 555059 [No Abstract] [Full Text] [Related]
18. New concepts for phase I trials: evaluating new drugs combined with radiation therapy. Deutsch E; Soria JC; Armand JP Nat Clin Pract Oncol; 2005 Sep; 2(9):456-65. PubMed ID: 16264990 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer. Altundag O; Altundag K; Morandi P; Hanrahan E Oral Oncol; 2005 Apr; 41(4):435. PubMed ID: 15792617 [No Abstract] [Full Text] [Related]
20. Cancer treatment: the last 25 years. McVie JG Cancer Treat Rev; 1999 Dec; 25(6):323-31. PubMed ID: 10644499 [No Abstract] [Full Text] [Related] [Next] [New Search]